Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziyi Peng

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Molecular Medicine (Cambridge, Mass.)|July 29, 2025
MKRN1 degrades AGC1 to trigger chemotherapy resistance of colorectal CancerYixuan Wang, Mu Qiao, Jing Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2024
Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II TrialLei Wang, Mengting Sun, Jinyang Li, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Molecular Medicine (Cambridge, Mass.)|July 29, 2025
MKRN1 degrades AGC1 to trigger chemotherapy resistance of colorectal CancerYixuan Wang, Mu Qiao, Jing Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2024
Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II TrialLei Wang, Mengting Sun, Jinyang Li, et al.
Pageof 7